Thermo Fisher Scientific Expands Scientific Advisory Board

  Thermo Fisher Scientific Expands Scientific Advisory Board

Dr. Klaus Lindpaintner to Lead Strategic Development of Innovative Analytical
                                 Technologies

Business Wire

WALTHAM, Mass. -- November 07, 2012

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science,
today announced that Klaus Lindpaintner, MD, MPH, and Edison T. Liu, MD, have
joined its Scientific Advisory Board. The board was created in 2010 to
formalize the two-way exchange of technological information between the
company and representatives from some of the world’s premier centers of
health, science and education.

Klaus Lindpaintner, MD, MPH, Chief Scientific Officer, Analytical
Technologies, Thermo Fisher Scient ...

Klaus Lindpaintner, MD, MPH, Chief Scientific Officer, Analytical
Technologies, Thermo Fisher Scientific (Photo: Business Wire)

Dr. Lindpaintner became an internal member of the Scientific Advisory Board
after recently joining Thermo Fisher in the newly created role of chief
scientific officer, analytical technologies. In this highly strategic
position, Dr. Lindpaintner will look for opportunities to maximize the impact
of the company’s leading portfolio of analytical technologies by assessing the
evolving needs of the global life sciences industry.

“I’m pleased to welcome Klaus to our company,” said Marc N. Casper, president
and chief executive officer of Thermo Fisher. “In these roles, Klaus will help
us accelerate our long-term growth by looking for new opportunities to
leverage our unique depth of capabilities in analytical technologies, ensuring
a homogenous approach to our R&D efforts and raising Thermo Fisher’s profile
as the innovation leader in our industry.”

Dr. Lindpaintner holds Bachelor of Science and Medical Doctorate degrees from
the University of Innsbruck in Austria, and a Master of Public Health degree
from Harvard University. He served as a Roche Distinguished Scientist and
director of the Roche Center for Medical Genomics, as well as global head of
molecular medicine policy and external affairs for F. Hoffman-La Roche AG.
Most recently, Dr. Lindpaintner was the chief scientific officer and vice
president of research and development at Strategic Diagnostics Inc.

His numerous academic appointments include positions at Jiao-Tong University
in Shanghai, Stanford University, Harvard University and the University of
London. He is also a Fellow of the American College of Physicians and a Fellow
of the American College of Medical Genetics.

Dr. Liu, the seventh outside member of the company’s Scientific Advisory
Board, is an international leader in cancer biology, genomics, human genetics
and molecular biology. He is president and chief executive officer of The
Jackson Laboratory, an internationally renowned research center dedicated to
discovering the genetic basis for preventing, treating and curing human
disease.

“Dr. Liu is a pioneer in cancer research, and his unique experience as both
clinician and scientist will bring a valuable perspective to our Scientific
Advisory Board,” Casper said. “We’re fortunate to have Dr. Liu as a member of
this influential board, which plays an important role in guiding our
innovation strategy.”

Dr. Liu also founded the Genome Institute of Singapore in 2001, building it
into a major research institute of 27 laboratory groups. From 1996 to 2001, he
was scientific director of the National Cancer Institute's Division of
Clinical Sciences in Bethesda, Md. Dr. Liu earned his Bachelor of Science
degree in chemistry and psychology, as well as his Medical Doctorate, at
Stanford University. He served his internship and residency at Washington
University's Barnes Hospital in St. Louis, followed by an oncology fellowship
at Stanford.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE:TMO) is the world leader in serving
science. Our mission is to enable our customers to make the world healthier,
cleaner and safer. With revenues of $12 billion, we have approximately 39,000
employees and serve customers within pharmaceutical and biotech companies,
hospitals and clinical diagnostic labs, universities, research institutions
and government agencies, as well as in environmental and process control
industries. We create value for our key stakeholders through three premier
brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which
offer a unique combination of innovative technologies, convenient purchasing
options and a single solution for laboratory operations management. Our
products and services help our customers solve complex analytical challenges,
improve patient diagnostics and increase laboratory productivity. Visit
www.thermofisher.com.

Photos/MultimediaGallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50468372&lang=en

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50468372&lang=en

Contact:

Thermo Fisher Scientific Inc.
Media Contact Information:
Ron O’Brien, 781-622-1242
ron.obrien@thermofisher.com
www.thermofisher.com
or
Investor Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com